These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2209320)

  • 1. Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM.
    Jones IR; Swai A; Taylor R; Miller M; Laker MF; Alberti KG
    Diabetes Care; 1990 Aug; 13(8):855-63. PubMed ID: 2209320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bezafibrate on metabolic profiles in non-insulin-dependent diabetes mellitus.
    Alberti KG; Jones IR; Laker MF; Swai AB; Taylor R
    J Cardiovasc Pharmacol; 1990; 16 Suppl 9():S21-4; discussion S24-5. PubMed ID: 1710741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
    Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G
    Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects.
    Suter SL; Nolan JJ; Wallace P; Gumbiner B; Olefsky JM
    Diabetes Care; 1992 Feb; 15(2):193-203. PubMed ID: 1547676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM.
    Jeppesen J; Zhou MY; Chen YD; Reaven GM
    Diabetes Care; 1994 Oct; 17(10):1093-9. PubMed ID: 7821127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control.
    Reaven GM; Johnston P; Hollenbeck CB; Skowronski R; Zhang JC; Goldfine ID; Chen YD
    J Clin Endocrinol Metab; 1992 May; 74(5):1020-6. PubMed ID: 1569149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gemfibrozil treatment in sulfonylurea-treated patients with noninsulin-dependent diabetes mellitus.
    Shen DC; Fuh MM; Shieh SM; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1991 Sep; 73(3):503-10. PubMed ID: 1874929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
    Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
    Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a slow release formulation of bezafibrate on lipids, glucose homeostasis, platelets and fibrinogen in type II diabetics: a pilot study.
    Mathur S; Barradas MA; Mikhailidis DP; Dandona P
    Diabetes Res; 1990 Jul; 14(3):133-8. PubMed ID: 2132185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities.
    Lewis GF; O'Meara NM; Soltys PA; Blackman JD; Iverius PH; Pugh WL; Getz GS; Polonsky KS
    J Clin Endocrinol Metab; 1991 Apr; 72(4):934-44. PubMed ID: 2005221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 24 hours of starvation on plasma glucose and insulin concentrations in subjects with untreated non-insulin-dependent diabetes mellitus.
    Gannon MC; Nuttall FQ; Lane JT; Fang S; Gupta V; Sandhofer CR
    Metabolism; 1996 Apr; 45(4):492-7. PubMed ID: 8609837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
    Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM
    Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved glucose tolerance after effective lipid-lowering therapy with bezafibrate in a patient with lipoatrophic diabetes mellitus: a putative role for Randle's cycle in its pathogenesis?
    Panz VR; Wing JR; Raal FJ; Kedda MA; Joffe BI
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):365-8. PubMed ID: 9156048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
    McMahon M; Marsh HM; Rizza RA
    Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients.
    Wu MS; Johnston P; Sheu WH; Hollenbeck CB; Jeng CY; Goldfine ID; Chen YD; Reaven GM
    Diabetes Care; 1990 Jan; 13(1):1-8. PubMed ID: 2404714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus.
    Chen YD; Swami S; Skowronski R; Coulston A; Reaven GM
    J Clin Endocrinol Metab; 1993 Jan; 76(1):172-7. PubMed ID: 8421086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM.
    Reaven GM; Hollenbeck C; Jeng CY; Wu MS; Chen YD
    Diabetes; 1988 Aug; 37(8):1020-4. PubMed ID: 3292322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-prandial metabolism of triglyceride-rich lipoproteins in non-insulin-dependent diabetic patients before and after bezafibrate treatment.
    Attia N; Durlach V; Roche D; Paul JL; Soni T; Zahouani A; Landron F; Labrousse F; Leutenegger M; Girard-Globa A
    Eur J Clin Invest; 1997 Jan; 27(1):55-63. PubMed ID: 9041378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.
    Schwartz EA; Koska J; Mullin MP; Syoufi I; Schwenke DC; Reaven PD
    Atherosclerosis; 2010 Sep; 212(1):217-22. PubMed ID: 20557887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.
    Fraze E; Donner CC; Swislocki AL; Chiou YA; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1985 Nov; 61(5):807-11. PubMed ID: 3900120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.